Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 28 August 2024 31 August 2025 31 August 2025 15922529 Dr Naeemah Haji iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15922529 2024-08-27 15922529 2025-08-31 15922529 2024-08-28 2025-08-31 15922529 frs-core:CurrentFinancialInstruments 2025-08-31 15922529 frs-bus:PrivateLimitedCompanyLtd 2024-08-28 2025-08-31 15922529 frs-bus:FilletedAccounts 2024-08-28 2025-08-31 15922529 frs-bus:Micro-entities 2024-08-28 2025-08-31 15922529 frs-bus:AuditExempt-NoAccountantsReport 2024-08-28 2025-08-31 15922529 frs-bus:Director1 2024-08-28 2025-08-31
Registered number: 15922529
Hackney Medical Ltd
Financial Statements
For The Year Ended 31 August 2025
Mibsons Limited
Chartered Certified Accountants
51 Coopers Road
Handsworth Wood
Birmingham
B20 2JU
Balance Sheet
Registered number: 15922529
2025
£
Fixed assets 26,455
Current assets 35,471
Creditors: Amounts Falling Due Within One Year (34,411 )
NET CURRENT ASSETS 1,060
TOTAL ASSETS LESS CURRENT LIABILITIES 27,515
Accruals and deferred income (960 )
NET ASSETS 26,555
CAPITAL AND RESERVES 26,555

Notes

1. General Information
Hackney Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15922529 . The registered office is 12 Westmorland Road, London, England, E17 8JA.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Naeemah Haji
Director
29th May 2026